Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
about
The use of lentinan for treating gastric cancerVocal Fold Augmentation with Beta Glucan Hydrogel Cross-Linked by γ Irradiation for Enhanced Duration of Effect: In Vivo Animal StudyBeta-glucan contamination of pharmaceutical products: How much should we accept?Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitusA Low Glycaemic Index Diet Incorporating Isomaltulose Is Associated with Lower Glycaemic Response and Variability, and Promotes Fat Oxidation in Asians.Hepatoprotective bioactivity of the glycoprotein, antrodan, isolated from Antrodia cinnamomea mycelia.Protective effects of beta glucan and gliclazide on brain tissue and sciatic nerve of diabetic rats induced by streptozosinPotential effects of nichi glucan as a food supplement for diabetes mellitus and hyperlipidemia: preliminary findings from the study on three patients from India.Effects of Pediococcus parvulus 2.6 and its exopolysaccharide on plasma cholesterol levels and inflammatory markers in mice.Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet.Chemistry, physico-chemistry and applications linked to biological activities of β-glucans.Cholesterol-lowering effects of oat β-glucan.Skin health promotion effects of natural beta-glucan derived from cereals and microorganisms: a review.An evidence-based systematic review of beta-glucan by the natural standard research collaboration.Preparation, characterization, and biological properties of β-glucans.Hypoglycemic activity of the Baker's yeast β-glucan in obese/type 2 diabetic mice and the underlying mechanism.Identification of weak and gender specific effects in a short 3 weeks intervention study using barley and oat mixed linkage β-glucan dietary supplements: a human fecal metabolome study by GC-MSClinical and Physiological Perspectives of β-Glucans: The Past, Present, and Future.Whole Grains in Amelioration of Metabolic Derangements.Hypoglycemic and Antidiabetic Effect of Pleurotus sajor-caju Aqueous Extract in Normal and Streptozotocin-Induced Diabetic Rats.Hypoglycemic and Hypocholesterolemic Effects of Botryosphaeran from Botryosphaeria rhodina MAMB-05 in Diabetes-Induced and Hyperlipidemia Conditions in Rats.Protective effects of beta glucan in brain tissues of post-menopausal rats: a histochemical and ultra-structural study.
P2860
Q24619416-8D137A14-5B76-42E2-9F0B-9494D06EAAA9Q27315221-61158696-CDD2-4A1A-A3B5-023EA372A34FQ28077957-2844DCAA-E4DD-47BC-86C3-2035A2AEA76AQ33706752-F90D5AE1-CD7E-4F7D-B8AA-B32D901E8545Q33749390-3BAD85F8-1D21-43FA-8390-640B2D716C15Q35137263-BE0F672B-7316-472D-A974-A550B14CE91BQ35691639-11EF9F3F-9B04-4CBF-ABEA-C097CB6EF276Q36487697-7F947A7C-D656-4461-89C5-ECB0DDA1A4FEQ36575435-BF86077E-84E2-48D4-B9DD-79808451073FQ36869289-A945FED2-75F5-4407-9882-B812476465DCQ37829352-362BB79C-88BB-4173-B882-B5B46532C9A2Q37883463-3C98C8B4-F669-4796-B0E4-E8256298C849Q38089702-AAA02249-993C-493A-839F-2EA79F3698A2Q38264166-C3B3B260-DF84-47FB-AB34-58E50EA39B8EQ39151353-3A335B96-DF5F-423F-B843-F5A19CE6080AQ39617018-88C9A1D6-0D83-4108-904F-1B95D9850811Q41459266-A374DDC2-C65C-48B8-B603-2862E4353B42Q41660956-799F9086-BA72-403C-B4AC-1A0302736FCEQ41700402-9D28DD3B-FFC5-4D81-82B4-C755D0C0CAEBQ41835258-6BC1E326-2D6F-414B-BF06-1DB581108BCCQ42217765-76B12357-23B4-46E6-838D-8716368B08B2Q50969712-1DB78B58-4606-4580-A161-8F2B7C03D008
P2860
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
@en
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
@nl
type
label
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
@en
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
@nl
prefLabel
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
@en
Beta-glucans in the treatment of diabetes and associated cardiovascular risks.
@nl
P2860
P921
P356
P1476
Beta-glucans in the treatment of diabetes and associated cardiovascular risks
@en
P2093
Kenneth Raymond
P2860
P304
P356
10.2147/VHRM.S3803
P407
P577
2008-01-01T00:00:00Z